In a patient population treated with CD-19 CAR-T therapy, elevated troponin levels were noticed with older patients that presented with common cardiovascular risk factors such as diabetes, hypertension, hyperlipidemia, etc. Higher troponin levels were also observed in accordance with higher CRS grades and cardiotoxicity [107]. Here, CD19 is linked to congenital rubella syndrome.